Carrier-Free Self-Assembled Nanomedicines for Promoting Apoptosis and Inhibiting Proliferation in Hepatocellular Carcinoma

ACS Biomater Sci Eng. 2024 Jul 8;10(7):4347-4358. doi: 10.1021/acsbiomaterials.4c00390. Epub 2024 Jun 6.

Abstract

In order to improve the effectiveness of tumor treatment and reduce the toxic side effects of drugs, we formed carrier-free multifunctional nanoparticles (BI NPs) by noncovalent interaction of berberine hydrochloride and IR780. BI NPs possessed the synergistic effects of promoting apoptosis, inhibiting proliferation and metastasis of tumors, and phototherapeutic treatment. Dispersive and passive targeting ability retention (EPR) effects of BI NPs on tumor sites in vivo could be monitored by fluorescence imaging. In addition, BI NPs exhibited effective reactive oxygen species (ROS) generation and photothermal conversion capabilities, photodynamic therapy (PDT), and photothermal therapy (PTT). Importantly, BI NPs inhibit tumor suppression through the AMPK/PI3K/AKT signaling pathway to inhibit tumor proliferation and metastasis. BI NPs not only have efficient in vivo multimodal therapeutic effects but also have good biosafety and potential clinical applications.

Keywords: PDT; PTT; berberine; carrier-free; multimodal therapy.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Apoptosis* / drug effects
  • Berberine / chemistry
  • Berberine / pharmacology
  • Berberine / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / pathology
  • Cell Line, Tumor
  • Cell Proliferation* / drug effects
  • Humans
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / pathology
  • Mice
  • Mice, Inbred BALB C
  • Nanomedicine* / methods
  • Nanoparticles* / chemistry
  • Nanoparticles* / therapeutic use
  • Photochemotherapy / methods
  • Photothermal Therapy
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species
  • Berberine
  • Antineoplastic Agents